NCT06934044 A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1
NCT06903065 A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06892379 A Study of HS-20110 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06884618 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s) Status RECRUITING Phase PHASE1
NCT06883240 An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment Status RECRUITING Phase N/A
NCT06880328 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia Status COMPLETED Phase PHASE1
NCT06863961 A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06862869 Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy Status RECRUITING Phase N/A
NCT06847542 A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD Status RECRUITING Phase PHASE3
NCT06826612 A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease Status RECRUITING Phase PHASE1/PHASE2
NCT06819891 A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE3
NCT06819878 A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease Status RECRUITING Phase PHASE3
NCT06816017 A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC) Status WITHDRAWN Phase PHASE1
NCT06809608 A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081 Status COMPLETED Phase PHASE1
NCT06806033 A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Status RECRUITING Phase PHASE2
NCT06795048 A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06793215 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06790693 A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Status RECRUITING Phase PHASE3
NCT06780150 A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS) Status RECRUITING Phase N/A
NCT06774859 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms Status COMPLETED Phase PHASE3